Published in Circulation on October 15, 1996
Echocardiography in translational research: of mice and men. J Am Soc Echocardiogr (2008) 1.84
Brief periods of nitric oxide inhalation protect against myocardial ischemia-reperfusion injury. Anesthesiology (2008) 1.77
Inhaled NO as a viable antiadhesive therapy for ischemia/reperfusion injury of distal microvascular beds. J Clin Invest (1998) 1.68
Increased adhesion and aggregation of platelets lacking cyclic guanosine 3',5'-monophosphate kinase I. J Exp Med (1999) 1.24
Inhaled NO as a therapeutic agent. Cardiovasc Res (2007) 1.23
Extrapulmonary effects of inhaled nitric oxide: role of reversible S-nitrosylation of erythrocytic hemoglobin. Proc Am Thorac Soc (2006) 1.15
Nitric oxide, platelet function, myocardial infarction and reperfusion therapies. Heart Fail Rev (2003) 0.88
Comparative antiplatelet effects of aspirin, vapiprost and GR144053, a GPIIb/IIIa antagonist, with a special reference to the role of platelet microaggregates. Br J Pharmacol (1999) 0.85
Comparing beneficial effects of inhaled nitric oxide to L-arginine in necrotizing enterocolitis model in neonatal rats. Pediatr Surg Int (2012) 0.75
The genome of black cottonwood, Populus trichocarpa (Torr. & Gray). Science (2006) 21.03
Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature (1995) 9.86
Inhaled nitric oxide for the adult respiratory distress syndrome. N Engl J Med (1993) 6.22
Apoptosis in myocytes in end-stage heart failure. N Engl J Med (1996) 6.19
The six-minute walk test predicts peak oxygen uptake and survival in patients with advanced heart failure. Chest (1996) 5.29
The classification of staphylococci from colonized ventriculo-atrial shunts. J Clin Pathol (1969) 3.79
Extracorporeal membrane oxygenation in severe acute respiratory failure. A randomized prospective study. JAMA (1979) 3.69
Inhaled nitric oxide in persistent pulmonary hypertension of the newborn. Lancet (1992) 3.30
Inhaled nitric oxide and persistent pulmonary hypertension of the newborn. The Inhaled Nitric Oxide Study Group. N Engl J Med (1997) 3.13
Influence of the implantable cardioverter/defibrillator on sudden death and total mortality in patients evaluated for cardiac transplantation. Circulation (1995) 2.97
Preserved right ventricular ejection fraction predicts exercise capacity and survival in advanced heart failure. J Am Coll Cardiol (1995) 2.84
Inhaled nitric oxide. A selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction. Circulation (1991) 2.62
Adenoviral gene transfer of SERCA2a improves left-ventricular function in aortic-banded rats in transition to heart failure. Proc Natl Acad Sci U S A (2000) 2.45
Apoptosis in heart failure: release of cytochrome c from mitochondria and activation of caspase-3 in human cardiomyopathy. Proc Natl Acad Sci U S A (1999) 2.42
Cloning and expression of a cDNA encoding human endothelium-derived relaxing factor/nitric oxide synthase. J Biol Chem (1992) 2.25
Localized expression of the atrial natriuretic factor gene during cardiac embryogenesis. Genes Dev (1987) 2.24
Insights from three-dimensional echocardiography into the mechanism of functional mitral regurgitation: direct in vivo demonstration of altered leaflet tethering geometry. Circulation (1997) 2.22
Modulation of ventricular function through gene transfer in vivo. Proc Natl Acad Sci U S A (1998) 2.19
Electrocardiographic and clinical criteria for recognition of acute myocardial infarction based on analysis of 3,697 patients. Am J Cardiol (1983) 2.18
Effects of targeted neuronal nitric oxide synthase gene disruption and nitroG-L-arginine methylester on the threshold for isoflurane anesthesia. Anesthesiology (1995) 2.13
Recommendations for end-of-life care in the intensive care unit: The Ethics Committee of the Society of Critical Care Medicine. Crit Care Med (2001) 2.12
Pulmonary hypertension in severe acute respiratory failure. N Engl J Med (1977) 2.09
Neonatal atria and ventricles secrete atrial natriuretic factor via tissue-specific secretory pathways. Cell (1986) 1.98
The thin-cap fibroatheroma: a type of vulnerable plaque: the major precursor lesion to acute coronary syndromes. Curr Opin Cardiol (2001) 1.97
Digoxin therapy and mortality after myocardial infarction. Experience in the MILIS Study. N Engl J Med (1986) 1.96
Endothelial nitric oxide synthase limits left ventricular remodeling after myocardial infarction in mice. Circulation (2001) 1.89
The pulmonary vascular lesions of the adult respiratory distress syndrome. Am J Pathol (1983) 1.88
Pathologic assessment of the vulnerable human coronary plaque. Heart (2004) 1.88
Low concentrations of nitric oxide increase oxygen affinity of sickle erythrocytes in vitro and in vivo. J Clin Invest (1997) 1.87
Noninvasive estimation of the instantaneous first derivative of left ventricular pressure using continuous-wave Doppler echocardiography. Circulation (1991) 1.84
Emotional and behavioral predictors of preschool peer ratings. Child Dev (1990) 1.82
Genome variation in Cryptococcus gattii, an emerging pathogen of immunocompetent hosts. MBio (2011) 1.76
Inaccuracies of nitric oxide delivery systems during adult mechanical ventilation. Anesthesiology (1997) 1.75
Sustained pulmonary hypertension and right ventricular hypertrophy after chronic hypoxia in mice with congenital deficiency of nitric oxide synthase 3. J Clin Invest (1998) 1.72
Ventilatory management of severe acute respiratory failure for Y2K. Anesthesiology (1999) 1.70
Interaction of genetic deficiency of endothelial nitric oxide, gender, and pregnancy in vascular response to injury in mice. J Clin Invest (1998) 1.65
Pulmonary vasoconstriction and hypertension in mice with targeted disruption of the endothelial nitric oxide synthase (NOS 3) gene. Circ Res (1997) 1.63
Inhaled nitric oxide selectively reverses human hypoxic pulmonary vasoconstriction without causing systemic vasodilation. Anesthesiology (1993) 1.63
Nebulized sildenafil is a selective pulmonary vasodilator in lambs with acute pulmonary hypertension. Crit Care Med (2001) 1.58
Acute coronary reocclusion after thrombolysis with recombinant human tissue-type plasminogen activator: prevention by a maintenance infusion. Circulation (1986) 1.55
Localizing antithrombotic and vasodilatory activity with a novel, ultrafast nitric oxide donor. J Med Chem (1996) 1.54
Effect of vesnarinone on cardiac function in patients with severe congestive heart failure. Am Heart J (1998) 1.52
Dental care for children and young people who have a hearing impairment. Br Dent J (2000) 1.52
Comparative effects of aspirin, a synthetic thrombin inhibitor and a monoclonal antiplatelet glycoprotein IIb/IIIa antibody on coronary artery reperfusion, reocclusion and bleeding with recombinant tissue-type plasminogen activator in a canine preparation. J Am Coll Cardiol (1990) 1.51
Nucleotide sequences of the human and mouse atrial natriuretic factor genes. Science (1984) 1.51
Influence of orifice geometry and flow rate on effective valve area: an in vitro study. J Am Coll Cardiol (1990) 1.51
Mechanism of ischemic mitral regurgitation with segmental left ventricular dysfunction: three-dimensional echocardiographic studies in models of acute and chronic progressive regurgitation. J Am Coll Cardiol (2001) 1.51
Regulation of cardiac hypertrophy in vivo by the stress-activated protein kinases/c-Jun NH(2)-terminal kinases. J Clin Invest (1999) 1.50
Sp110 localizes to the PML-Sp100 nuclear body and may function as a nuclear hormone receptor transcriptional coactivator. Mol Cell Biol (2000) 1.49
Surgery for post-myocardial infarct ventricular septal defect. Ann Surg (1977) 1.49
Inhaled nitric oxide improves exercise capacity in patients with severe heart failure and right ventricular dysfunction. Am J Cardiol (1998) 1.47
Platelet factor 4 injection produces acute pulmonary hypertension in the awake lamb. Anesthesiology (1995) 1.46
Inotropic effect of nicardipine in patients with heart failure: assessment by left ventricular end-systolic pressure-volume analysis. J Am Coll Cardiol (1989) 1.44
Kistrin, a polypeptide platelet GPIIb/IIIa receptor antagonist, enhances and sustains coronary arterial thrombolysis with recombinant tissue-type plasminogen activator in a canine preparation. Circulation (1991) 1.44
Inspiratory muscle training in patients with chronic heart failure awaiting cardiac transplantation: results of a pilot clinical trial. Phys Ther (1997) 1.43
Quantitation of acute myocardial infarct size by nuclear magnetic resonance imaging. J Am Coll Cardiol (1990) 1.43
Papillary muscle displacement causes systolic anterior motion of the mitral valve. Experimental validation and insights into the mechanism of subaortic obstruction. Circulation (1995) 1.42
Atrial natriuretic factor gene expression in ventricles of rats with spontaneous biventricular hypertrophy. J Clin Invest (1988) 1.42
Inhaled nitric oxide for adult respiratory distress syndrome after pulmonary resection. Ann Thorac Surg (1998) 1.41
Comparison of enzymatic and anatomic estimates of myocardial infarct size in man. Circulation (1984) 1.41
Inhaled nitric oxide delivery by anesthesia machines. Anesth Analg (2000) 1.40
Intraaortic balloon pumping for ventricular septal defect or mitral regurgitation complicating acute myocardial infarction. Circulation (1973) 1.40
Epidemiological approach to quality assessment in echocardiographic diagnosis. J Am Coll Cardiol (1999) 1.38
Effects of disopyramide on left ventricular diastolic function in hypertrophic cardiomyopathy. Am J Cardiol (1994) 1.38
Design of a new surgical approach for ventricular remodeling to relieve ischemic mitral regurgitation: insights from 3-dimensional echocardiography. Circulation (2000) 1.37
Improved results of surgical management of postinfarction ventricular septal rupture. Ann Surg (1982) 1.37
Acute left ventricular dysfunction during unsuccessful weaning from mechanical ventilation. Anesthesiology (1988) 1.35
Differential sensitivity of erythrocyte-rich and platelet-rich arterial thrombi to lysis with recombinant tissue-type plasminogen activator. A possible explanation for resistance to coronary thrombolysis. Circulation (1989) 1.35
Use of sublingual nitroglycerin in congestive failure following acute myocardial infarction. Circulation (1972) 1.35
A dilemma for the 1990s. Choosing appropriate experimental animal model for the prevention of restenosis. Circulation (1992) 1.34
Adenovirus-mediated gene transfer of cGMP-dependent protein kinase increases the sensitivity of cultured vascular smooth muscle cells to the antiproliferative and pro-apoptotic effects of nitric oxide/cGMP. J Biol Chem (1998) 1.34
Bronchodilator action of inhaled nitric oxide in guinea pigs. J Clin Invest (1992) 1.34
The vascular biology of nitric oxide and its role in atherogenesis. Annu Rev Med (1996) 1.34
Ventricular septal rupture: a review of clinical and physiologic features and an analysis of survival. Circulation (1981) 1.34
Comparison between the effects of nitroprusside and nitroglycerin on ischemic injury during acute myocardial infarction. Circulation (1976) 1.33
Seal lungs collapse during free diving: evidence from arterial nitrogen tensions. Science (1985) 1.30
Chordal cutting: a new therapeutic approach for ischemic mitral regurgitation. Circulation (2001) 1.29
Nitric oxide decreases stability of mRNAs encoding soluble guanylate cyclase subunits in rat pulmonary artery smooth muscle cells. J Clin Invest (1997) 1.28
Thromboxane receptor blockade prevents pulmonary hypertension induced by heparin-protamine reactions in awake sheep. Circulation (1990) 1.28
Coronary thrombolysis with recombinant human tissue-type plasminogen activator: a prospective, randomized, placebo-controlled trial. Circulation (1984) 1.27
Pulmonary fibrosis in severe acute respiratory failure. Am Rev Respir Dis (1979) 1.27
Inhaled nitric oxide in congenital heart disease. Circulation (1993) 1.26
Rapid and sustained coronary artery recanalization with combined bolus injection of recombinant tissue-type plasminogen activator and monoclonal antiplatelet GPIIb/IIIa antibody in a canine preparation. Circulation (1988) 1.25
Hemoglobin concentrations and blood gas tensions of free-diving Weddell seals. J Appl Physiol (1985) (1986) 1.25
Klippel-Trénaunay syndrome with multiple pulmonary emboli--an unusual cause of progressive pulmonary dysfunction. J Vasc Surg (1995) 1.25
Identification and characterization of a leukocyte-specific component of the nuclear body. J Biol Chem (1996) 1.24
Leukotriene D4: a potent coronary artery vasoconstrictor associated with impaired ventricular contraction. Science (1982) 1.23
Platelet consumption and sequestration in severe acute respiratory failure. Am Rev Respir Dis (1980) 1.22
Combined influence of ventricular loading and relaxation on the transmitral flow velocity profile in dogs measured by Doppler echocardiography. Circulation (1988) 1.21